1. Background {#sec115362}
=============

Injection drug is one of the main modes of HIV transmission in many parts of the world, particularly in industrialized and middle-income countries, including many countries in Asia ([@A26159R1], [@A26159R2]). The recent global estimation in 2014 indicates that there are 12.7 million Injecting Drug Users (IDUs), and 13.1% of them are living with HIV ([@A26159R3]). The main behaviors that increase the risk of HIV infection and other blood borne diseases such as hepatitis B and C among IDUs are using non-sterile needles and other injecting equipment as well as engaging in unprotected sex practices ([@A26159R4]).

In the absence of cure for HIV infection, prevention is the best strategy for its control within the communities ([@A26159R5]). A number of prevention strategies are implemented among IDUs around the world. Some interventions such as needle and syringe provision aim to reduce unsafe injection ([@A26159R6], [@A26159R7]). Other approaches aim to lower the risk of sexual transmission by distribution of condoms and education of safe sex ([@A26159R7]-[@A26159R9]). Recently, the interventions on personal and drug injection networks of IDUs have been greatly taken into account by many health policymakers ([@A26159R10]-[@A26159R12]). There is evidence that shows a higher percentage of drug injectors in the social network of IDUs are associated with increase in their risky behavior ([@A26159R12], [@A26159R13]).

The key outcome of interest in all strategies is the prevention of HIV and viral hepatitis (B, C) transmission among IDUs ([@A26159R5]). For policymakers and harm reductionists who are interested in evaluating the efficacy of such programs and tracing the trends over time, applying a simple, brief, and valid measure that incorporates different dimensions of HIV transmission risks among IDUs may be more advantageous than looking at individual outcomes ([@A26159R14]). An effective scale to measure the mixed nature of HIV transmission risks among IDUs should address all aspects of HIV transmission, including injecting drugs, sexual behaviors, and risk network characteristics of individuals.

Although there are several scales that measure HIV transmission risks among populations at higher risk of HIV infection (e.g. men who have sex with men) ([@A26159R14]-[@A26159R16]), few scales are available for IDUs ([@A26159R17], [@A26159R18]) and none of them has been validated in Iran. Most of such scales have to obtain detailed and even insignificant information. The lack of risk network information within them is another limitation and indicates the demand for developing a multi-dimensional scale to capture HIV transmission by conducting a simple and brief interview that can be flexible in clinical settings, large scale surveys, and research.

2. Objectives {#sec115363}
=============

The aim of the present study was to create a brief scale applicable for policymakers, harm reductionists, and researchers for measuring HIV transmission risk among IDUs.

3. Patients and Methods {#sec115364}
=======================

We collected the data related to the risk of HIV transmission among IDUs as a part of the project entitled "social network analysis of IDUs in Kerman, Iran". From October 2013 to March 2014, three trained interviewers conducted face-to-face interviews with 147 IDUs. We used chain referral techniques to enroll a representative sample of IDUs from all affected sites, including drop-in centers, shelters, voluntary counseling, testing centers, and outreach spots. Eligible participants were individuals above 18 years old who had injected drugs at least once during the last year and had not participated in similar studies in the past 2 months. The interviews were conducted in two drop-in centers (DICs) in a very confidential setting. In some cases that the individuals were unwilling to complete the interviews at DICs, the interviewers completed the questionnaires on site.

To design a scale for measuring HIV transmission risk among IDUs, we specified 11 items, which address different dimensions of HIV risk taking behaviors/situations based on experts' opinions. The scale covered both injecting and sexual risk behaviors as well as risk network characteristics of individuals, use of stimulants, and engagement in methadone maintenance therapy (MMT).

High risk behaviors related to injection were as follows: history of needle sharing, the history of using shared cookers, cotton and rinse water; the number of needle sharing partners; average number of daily injections within the last 6 months; duration of time since first injection; and proportion of IDUs in the personal network of participants. The items related to sexual behaviors were as follows: the number of sexual partners, extent of using condoms during sexual intercourse, and whether the participants used a condom at last sex. We also asked the participants to specify if they used any types of stimulant drugs or currently engaged in MMT. [Table 1](#tbl29666){ref-type="table"} presents the items and related scores.

We applied exploratory factor analysis (EFA) with principal component extraction and varimax with Kaiser Normalization rotation to develop scales. Eigen values greater than 1 were used as a criterion for factor extraction. Items with loadings less than 0.3 were dropped. The Cronbach's α coefficient was calculated to estimate the internal consistency of the scale.

###### The 11 Initial Items to Design the HIV Transmission Scale

  No.      Item                                                                                                                                     Response Category          Score
  -------- ---------------------------------------------------------------------------------------------------------------------------------------- -------------------------- -------
  **1**    The extent to which respondents used a needle that already had been used by someone else within the past 6 months                                                   
                                                                                                                                                    Never                      0
                                                                                                                                                    Sometimes                  1
                                                                                                                                                    Usually                    2
                                                                                                                                                    Always                     3
  **2**    The extent to which respondents used cookers, rinse water, or cotton after someone else had already used them within the past 6 months                              
                                                                                                                                                    Never                      0
                                                                                                                                                    Sometimes                  1
                                                                                                                                                    Usually                    2
                                                                                                                                                    Always                     3
  **3**    The number of people that had used a syringe before respondents used it within the past 6 months                                                                    
                                                                                                                                                    None                       0
                                                                                                                                                    1 person                   1
                                                                                                                                                    2 persons                  2
                                                                                                                                                    3 persons                  3
                                                                                                                                                    4 persons                  4
                                                                                                                                                    5 persons                  5
                                                                                                                                                    6 persons or more          6
  **4**    The proportion of IDUs in personal network of respondents                                                                                                           
                                                                                                                                                    0                          0
                                                                                                                                                    1% - 24.9%                 1
                                                                                                                                                    25% - 49.9%                2
                                                                                                                                                    50% - 74.9%                3
                                                                                                                                                    ≥ 75%                      4
  **5**    The duration from the first injection                                                                                                                               
                                                                                                                                                    \< 5 y                     1
                                                                                                                                                    5 - 10 y                   2
                                                                                                                                                    \> 10 y                    3
  **6**    The average number of daily injections                                                                                                                              
                                                                                                                                                    Once a day or less         1
                                                                                                                                                    Twice a day                2
                                                                                                                                                    Three times a day          3
                                                                                                                                                    Four time a day            4
                                                                                                                                                    Five times a day or more   5
  **7**    The number of sexual partners within the past 6 months                                                                                                              
                                                                                                                                                    None                       0
                                                                                                                                                    1 person                   1
                                                                                                                                                    2 persons                  2
                                                                                                                                                    3 persons                  3
                                                                                                                                                    4 persons                  4
                                                                                                                                                    5 persons                  5
                                                                                                                                                    6 persons or more          6
  **8**    The extent of using condoms during sexual intercourse within the past 6 months                                                                                      
                                                                                                                                                    Never                      3
                                                                                                                                                    Sometimes                  2
                                                                                                                                                    Usually                    1
                                                                                                                                                    Always                     0
  **9**    The use of condoms during the last sexual intercourse                                                                                                               
                                                                                                                                                    Yes                        0
                                                                                                                                                    No                         1
  **10**   If the respondent is currently under MMT                                                                                                                            
                                                                                                                                                    Yes                        0
                                                                                                                                                    No                         1
  **11**   If the respondent used any stimulant drug within the past 6 months                                                                                                  
                                                                                                                                                    No                         0
                                                                                                                                                    Yes                        1

4. Results {#sec115365}
==========

The mean age of participants was 37 ± 9.32 years. Most of individuals were male (91%), single (50.1%), and educated up to guidance school (73.5%) ([Table 2](#tbl29667){ref-type="table"}).

We developed the final scale based on 7 items loaded on the first factor that accounted for 21% of variance. The variables and related coefficients are summarized in [Table 2](#tbl29667){ref-type="table"}. The Cronbach's α coefficient was 0.66, which is acceptable for brief scales. The mean score in the overall sample was 3.002 ± 2.33 with a median of 2.3 (range 0 - 11). The maximum possible score was 15.4. The mean score in injection subscale (items 1 - 4 in [Table 3](#tbl29668){ref-type="table"}) was 2.11 ± 1.88 with the median of 1.52 (range 0 - 9).The mean (± SD) and median in sexual behavior subscale (items 5 - 7 in [Table 3](#tbl29668){ref-type="table"}) were 0.88 (± 0.95) and 0.4, respectively (range 0 - 3.91).

###### The Demographic Characteristics of 147 Injecting Drug Users

  Characteristic                                                Value
  ------------------------------------------------------------- ------------
  **Age, y**                                                    
  Mean ± SD                                                     37 ± 9.32
  Minimum                                                       20
  Maximum                                                       36
  **Education** ^**[a](#fn29436){ref-type="table-fn"}**^        
  Illiterate or Primary school                                  52 (35.3)
  Guidance school                                               56 (38.1)
  High school and above                                         39 (26.5)
  **Marital status** ^**[a](#fn29436){ref-type="table-fn"}**^   
  Single                                                        76 (51.7)
  Married                                                       37 (25.2)
  Divorced                                                      30 (20.4)
  Widowed                                                       4 (2.7)
  **Gender** ^**[a](#fn29436){ref-type="table-fn"}**^           
  Male                                                          134 (91.2)
  Female                                                        13 (8.8)

^a^Values are presented as number (%).

###### Factor Loadings of Final 7 HIV Transmission Risk Items Among 147 Injecting Drug Users

  No      Item                                                                                                                                     Factor Loading
  ------- ---------------------------------------------------------------------------------------------------------------------------------------- ----------------
  **1**   The extent to which respondents used a needle that already had been used by someone else within the past 6 months                        0.84
  **2**   The number of people that had used a syringe before respondents used it within the past 6 months                                         0.82
  **3**   The extent to which respondents used cookers, rinse water, or cotton after someone else had already used them within the past 6 months   0.62
  **4**   The proportion of IDUs in the personal network of respondents                                                                            0.45
  **5**   The extent of using condoms during the sexual intercourses within the past 6 months                                                      0.52
  **6**   The number of sexual partners within the past 6 months                                                                                   0.40
  **7**   The use of condoms during the last sexual intercourse                                                                                    0.35

5. Discussion {#sec115366}
=============

The results of the present study indicate that employing a 7-item scale to measure the HIV transmission risk among IDUs may be useful for evaluation of intervention programs in this key group. In many studies, the focus of risk analysis is on discrete behaviors to identify trends in behaviors or to study the determinants of high risk behaviors in this population ([@A26159R19], [@A26159R20]). For a better understanding of the current status of HIV transmission risks among IDUs, looking simultaneously at multiple factors and conditions may provide better insight for policymakers and researchers into the mixed nature of HIV transmission risks and assist with identifying IDUs with higher risk of HIV acquisition or transmission based on their behaviors. Furthermore, measuring the impact of interventions on multiple discrete outcomes may increase the chance of type I errors by introducing the problem of multiplicity into the analysis ([@A26159R21]).

To prepare this scale; we used principal component analysis, a multivariate technique which simplifies a set of items to their linear combination in a way that they successively have a maximum variance for the data. The measure of internal consistency, the Cronbach α, was satisfactory, which indicates that summation of different items to construct a global scale for measuring HIV transmission risks is proper. This approach may be more statistically powerful and informative in etiologic research as well as program evaluation efforts.

Regarding high risk behaviors related to injection practice, the highest weight pertained to the needle sharing followed by the number of injection partners and sharing of injection equipment. These findings are supported by the literature that suggests the higher likelihood of HIV transmission among those who share needles with multiple partners than those who only share injection equipment such as cookers or rinse water ([@A26159R22]). In addition, the use of a condom during sexual intercourse is of much more significance than the number of sexual partners. Another item that was extracted in the final scale was proportion of IDUs in the personal network of participants. This item has been ignored in available scales while in many situations, the higher proportion of IDUs in personal networks of individuals has been associated with a higher rate of risky behaviors ([@A26159R12], [@A26159R13]). In addition, out of 11 items that we entered in the initial scale, 4 were dropped from the final model. These items were duration of injection, average number of daily injections, engagement in MMT program, and use of stimulant drugs within the last 6 months. As these items indirectly affect the risk of HIV transmission among IDUs, it is uninformative to retain them in this scale.

We asked about the high risk behaviors of IDUs during the last 6 months to take into account the turnover of their relations that usually exist among IDUs. In addition, we supposed that some questions such as the number of anal intercourse acts during the last month (that was considered by Darke and colleagues in a similar scale) does not necessarily affect the risk of HIV transmission ([@A26159R17]). Instead, the safety of sexual acts (e.g. use of condoms) is the main determinant of HIV transmission during sexual relationship. Therefore, such items dropped from our suggested scale.

In conclusion, applying a 7-item scale can help harm reductionists and clinical practitioners to simply measure the current status of HIV transmission risks among IDUs in a short period of time (3 - 5 minutes). It also provides an opportunity for policymakers to evaluate the impact of intervention programs by measuring the changes in HIV transmission risk by employing a comprehensive scale that captures different factors related to virus transmission. Undoubtedly, an effective rapport between interviewers and participants increase the validity of such self-reported data. Nevertheless, the cross-sectional nature of the data has limited our ability to assess the usefulness of scales in prediction of HIV seroconversion among IDUs. So, prospective cohort studies are needed to assess the predictive validity of scales.
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